ConductScience.org, home

Paper17525730

Immune reconstitution after allogeneic stem cell transplantation with reduced-intensity conditioning regimens.

Jiménez M and 2 others. Leukemia, 2007. Cited by 37 papers, by iCite.

Cite this record

ConductScience Library. Immune reconstitution after allogeneic stem cell transplantation with reduced-intensity conditioning regimens. Papers, record 17525730. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17525730

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Immune reconstitution after allogeneic stem cell transplantation with reduced-intensity conditioning regimens.
PubMed
Journal
Leukemia
PubMed
Year
2007
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Review
PubMed
Citations, by iCite
37
iCite
Relative citation ratio, by iCite
0.82
iCite
Revised in PubMed
2026-10-10
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Jiménez MM
2Ercilla GG
3Martínez CC

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Graft vs Host DiseaseMajor topic
Stem Cell TransplantationMajor topic
T-LymphocytesMajor topic
Transplantation ConditioningMajor topic
Graft vs Tumor Effect
Humans
Immunosuppressive Agents
Transplantation Chimera
Transplantation, Homologous

Source PubMed

Download CSV of topics

References97

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
112393628Characterization of human blood dendritic cell subsets.Blood2002https://conductscience.org/library/papers/12393628PubMed
215526016
Hematopoietic stem-cell transplantation from unrelated donors in elderly patients (age >55 years) with hematologic malignancies: older age is no longer a contraindication when using reduced intensity conditioning.
Leukemia2005https://conductscience.org/library/papers/15526016PubMed
312201954Dendritic cell recovery following nonmyeloablative allogeneic stem cell transplants.J Hematother Stem Cell Res2002https://conductscience.org/library/papers/12201954PubMed
416263578Immune recovery after conventional and non-myeloablative allogeneic stem cell transplantation.Leuk Lymphoma2005https://conductscience.org/library/papers/16263578PubMed
510449519Direct evidence for thymic function in adult humans.J Exp Med1999https://conductscience.org/library/papers/10449519PubMed
612931226Infectious complications following allogeneic HLA-identical sibling transplantation with antithymocyte globulin-based reduced intensity preparative regimen.Leukemia2003https://conductscience.org/library/papers/12931226PubMed
711233907T cell mixed chimerism is significantly correlated to a decreased risk of acute graft-versus-host disease after allogeneic stem cell transplantation.Transplantation2001https://conductscience.org/library/papers/11233907PubMed
89446633
Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases.
Blood1998https://conductscience.org/library/papers/9446633PubMed
916258529Kinetics of dendritic cell chimerism and T cell chimerism in allogeneic hematopoietic stem cell recipients.Bone Marrow Transplant2006https://conductscience.org/library/papers/16258529PubMed
1012472597Respiratory virus infections in transplant recipients after reduced-intensity conditioning with Campath-1H: high incidence but low mortality.Br J Haematol2002https://conductscience.org/library/papers/12472597PubMed
1114755322Third EBMT/AMGEN Workshop on reduced-intensity conditioning allogeneic haemopoietic stem cell transplants (RIC-HSCT), and panel consensus.Bone Marrow Transplant2004https://conductscience.org/library/papers/14755322PubMed
124398496Marrow transplanation in man following cyclophosphamide.Transplant Proc1971https://conductscience.org/library/papers/4398496PubMed
1312243978Recovery of lymphocyte and dendritic cell subsets following reduced intensity allogeneic bone marrow transplantation.Hematology2002https://conductscience.org/library/papers/12243978PubMed
1411593319Lymphocyte reconstitution following non-myeloablative hematopoietic stem cell transplantation follows two patterns depending on age and donor/recipient chimerism.Bone Marrow Transplant2001https://conductscience.org/library/papers/11593319PubMed
159872319Changes in thymic function with age and during the treatment of HIV infection.Nature1998https://conductscience.org/library/papers/9872319PubMed
169521319Dendritic cells and the control of immunity.Nature1998https://conductscience.org/library/papers/9521319PubMed
179034287Infectious morbidity in long-term survivors of allogeneic marrow transplantation is associated with low CD4 T cell counts.Am J Hematol1997https://conductscience.org/library/papers/9034287PubMed
1815846289Long-term immune recovery of patients undergoing allogeneic stem cell transplantation: a comparison with their respective sibling donors.Biol Blood Marrow Transplant2005https://conductscience.org/library/papers/15846289PubMed
1911274765Low-intensity conditioning is sufficient to ensure engraftment in matched unrelated bone marrow transplantation.Exp Hematol2001https://conductscience.org/library/papers/11274765PubMed
2012652467Persistence of host dendritic cells after transplantation is associated with graft-versus-host disease.Biol Blood Marrow Transplant2003https://conductscience.org/library/papers/12652467PubMed

See all 97 referencesDownload CSV of references

Cited by22

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 37 citations.

PMIDTitleJournalYearIn PapersSource
41408960Factors Affecting Immune Reconstitution Post-Allogeneic HSCT in Children: The Case for an Individualized Approach to Vaccination.Eur J Haematol2026https://conductscience.org/library/papers/41408960PubMed
40336916Epstein-Barr virus reactivation after haplo-peripheral blood stem cell transplantation in patients with hematological malignancies: immune reconstitution and influence on survival.Ther Adv Hematol2025https://conductscience.org/library/papers/40336916PubMed
38680716Kinetics of Recovery of Naïve and Memory T Cells in Acute Leukemia Patients after Allogeneic Stem Cell Transplantation Depending on Different GVHD Prophylaxis Regimens.Int J Hematol Oncol Stem Cell Res2024https://conductscience.org/library/papers/38680716PubMed
37389818Attenuated immunogenicity of SARS-CoV-2 vaccines and risk factors in stem cell transplant recipients: a meta-analysis.Blood Adv2023https://conductscience.org/library/papers/37389818PubMed
36105821Gamma delta T-cell reconstitution after allogeneic HCT: A platform for cell therapy.Front Immunol2022https://conductscience.org/library/papers/36105821PubMed
34057741A novel clinically relevant graft-versus-leukemia model in humanized mice.J Leukoc Biol2022https://conductscience.org/library/papers/34057741PubMed
31554929
Autoimmune cytopenias (AIC) following allogeneic haematopoietic stem cell transplant for acquired aplastic anaemia: a joint study of the Autoimmune Diseases and Severe Aplastic Anaemia Working Parties (ADWP/SAAWP) of the European Society for Blood and Marrow Transplantation (EBMT).
Bone Marrow Transplant2020https://conductscience.org/library/papers/31554929PubMed
30562587Rapid Acquisition of Cytomegalovirus-Specific T Cells with a Differentiated Phenotype, in Nonviremic Hematopoietic Stem Transplant Recipients Vaccinated with CMVPepVax.Biol Blood Marrow Transplant2019https://conductscience.org/library/papers/30562587PubMed
28991250Assessment of TREC, KREC and telomere length in long-term survivors after allogeneic HSCT: the role of GvHD and graft source and evidence for telomere homeostasis in young recipients.Bone Marrow Transplant2018https://conductscience.org/library/papers/28991250PubMed
28251017A Review of Myeloablative vs Reduced Intensity/Non-Myeloablative Regimens in Allogeneic Hematopoietic Stem Cell Transplantations.Balkan Med J2017https://conductscience.org/library/papers/28251017PubMed
27727179T Cell Receptor Excision Circle (TREC) Monitoring after Allogeneic Stem Cell Transplantation; a Predictive Marker for Complications and Clinical Outcome.Int J Mol Sci2016https://conductscience.org/library/papers/27727179PubMed
25961559Immune Reconstitution Kinetics following Intentionally Induced Mixed Chimerism by Nonmyeloablative Transplantation.PLoS One2015https://conductscience.org/library/papers/25961559PubMed
25867947Busulfan as a myelosuppressive agent for generating stable high-level bone marrow chimerism in mice.J Vis Exp2015https://conductscience.org/library/papers/25867947PubMed
25261095Cytomegalovirus shapes long-term immune reconstitution after allogeneic stem cell transplantation.Haematologica2015https://conductscience.org/library/papers/25261095PubMed
25099175Myc and AP-1 expression in T cells and T-cell activation in patients after hematopoietic stem cell transplantation.Clin Exp Med2015https://conductscience.org/library/papers/25099175PubMed
23103674Impact of lymphocyte and monocyte recovery on the outcomes of allogeneic hematopoietic SCT with fludarabine and melphalan conditioning.Bone Marrow Transplant2013https://conductscience.org/library/papers/23103674PubMed
22856463Effects of intensified conditioning on Epstein-Barr virus and cytomegalovirus infections in allogeneic hematopoietic stem cell transplantation for hematological malignancies.J Hematol Oncol2012https://conductscience.org/library/papers/22856463PubMed
22046566Future perspectives: therapeutic targeting of notch signalling may become a strategy in patients receiving stem cell transplantation for hematologic malignancies.Bone Marrow Res2011https://conductscience.org/library/papers/22046566PubMed
21427289Thymic T-cell development in allogeneic stem cell transplantation.Blood2011https://conductscience.org/library/papers/21427289PubMed
20831896Early lymphocyte recovery and outcomes after umbilical cord blood transplantation (UCBT) for hematologic malignancies.Biol Blood Marrow Transplant2011https://conductscience.org/library/papers/20831896PubMed

See all 22 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/17525730

GET https://conductscience.org/api/papers/v1/17525730/references?page=2